ACE2 and diabetes mellitus: There is emerging evidence that COVID-19 may cause new-onset DM and severe metabolic complications of pre-existing DM via ACE2 (insulin deficiency and increased risk of Diabetic Keto-Acidosis) [48, 62], which leads to challenges in clinical management and requires further investigation.